|
Adverse Effects
Citations 401-410 of 594 total displayed.
|
Past content
(since Mar 1998):
|
- Health Agencies Update
Promethazine Warning
- Tracy Hampton
JAMA 2005; 293: 921-b.
[Extract]
[Full text]
[PDF]
- Letters
Community-Acquired Pneumonia and Use of Gastric AcidSuppressive Drugs
- Robert T. Sataloff
JAMA 2005; 293: 795-b-796-b.
[Extract]
[Full text]
[PDF]
- Letters
Community-Acquired Pneumonia and Use of Gastric AcidSuppressive DrugsReply
- Robert J. F. Laheij; Miriam C. J. M. Sturkenboom; Jeanne Dieleman; Bruno H. C. Stricker; Jan B. M. J. Jansen
JAMA 2005; 293: 796.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Officials Halt NSAID Prevention Trials
- Tracy Hampton
JAMA 2005; 293: 664-665.
[Extract]
[Full text]
[PDF]
- Original Contributions
Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation: A Randomized Trial
- SPORTIF Executive Steering Committee for the SPORTIF V Investigators
JAMA 2005; 293: 690-698.
[Abstract]
[Full text]
[PDF]
- Editorials
XimelagatranPromises and Concerns
- Victor Gurewich
JAMA 2005; 293: 736-739.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Antidepressant Warning Focuses Attention on Unmet Need for Child Psychiatrists
- Sarah Ringold
JAMA 2005; 293: 537-538.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Experts Point to Lessons Learned From Controversy Over Rofecoxib Safety
- Tracy Hampton
JAMA 2005; 293: 413-414.
[Extract]
[Full text]
[PDF]
- Editorials
Arthritis Medicines and Cardiovascular Events"House of Coxibs"
- Eric J. Topol
JAMA 2005; 293: 366-368.
[Extract]
[Full text]
[PDF]
- JAMA Patient Page
Aspirin Sensitivity
- Sharon Parmet; Cassio Lynm; Richard M. Glass
JAMA 2004; 292: 3098.
[Extract]
[Full text]
[PDF]
|
|